1 TIP QANDLI DIABETDAGI DIABETIK POLINEYROPATIYANING TARQALISHI VA NEVROLOGIK XUSUSIYATLARI
##article.subject##:
1 tip qandli diabet, diabetic polineyropatiya, nevrologik xusisiyat##article.abstract##
Tahlil natijalari NIS LL ballari va kasallik davomiyligi o'rtasidagi statistik jihatdan muhim bog'liqlikni ko'rsatadi, ammo glikirlashgan gemoglobin darajasi va NIS LL ballari o'rtasida o'zaro bog'liqlik topilmadi. DPNning 2 va 3 bosqichlarida bemorlarning 77,5% da TSS shkalasi bo'yicha ijobiy neyropatik simptomlar kuzatildi. 28,6% bemorlar oyoqlaridagi uyushishdan shikoyat qilishdi, 26,9% bemorlarda oyoqlarning og'rig'i, 21,2% bemorlarda oyoqlar kuyishish hissi, 15,8% bemorlarda paresteziya kuzatildi. 1-tip diabetda DPN tarqalishi 68,3% ni tashkil etdi, shundan subklinik DPN 46,8%, simptomatik DPN 22,5% bemorlarda uchradi. Qandli diabetning 5 yilgacha bo’lgan davomiyligi bilan simptomatik DP bemorlarning 6% da, diabetning davomiyligi 5 yildan 10 yilgacha bo'lgan bemorlarning 14,7 %, diabetning davomiyligi 10 yildan oshganda 37,8 % da aniqlanadi.
Библиографические ссылки
Alon Abraham, Ari Breiner, Carolina Barnett, Hans D. Katzberg, Vera Bri Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy// Journal of the Neurological Sciences Volume 37915, August 2017, Pages 94-98
Alyce S. Adams, Brian Callaghan, Richard W. Grant // Overcoming barriers to diabetic polyneuropathy manageme nt in primary care Healthcare Volume 5, Issue 4, December 2017, Pages 171-173
Biryukova E., Gannenkova E., Solovieva I. Diabetic polyneuropathy: what have we achieved in understanding the problem? // RIJ, 2020 №3. Pp. 14-16
Cinzia Ciccacci, Andrea Latini, Carla Greco, Cristina Politi, Vincenza Spallone //Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes Journal of Diabetes and its Complications Volume 32, Issue 1, January 2018, Pages 11-17
Cristina Politi, Cinzia Ciccacci, Cinzia D’Amato, Giuseppe Novelli, Vincenza Spallone //Recent advances in exploring the genetic susceptibility to diabetic neuropathy Diabetes Research and Clinical Practice Volume 120, October 2016, Pages 198-208
Danita Weeracharoenku, Signe Toft Andersen, Supranee Niruthisard. Painful and non-painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues / // J Diabetes Investig 2019.Vol. 10. No. 5. Р.1148-1155.
Kris Rutten, Stacey A. Gould, Luke Bryden, Henri Doods, Anton Pekcec //Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic pain Behavioural Brain Research Volume 35017, September 2018, Pages 129-138
Loban D., Bychik M., Usova N. Clinical characteristics of patients with diabetic polyneuropathy // Actual problems of medicine. 2020.No. 21. S. 48-49.
Maher R. Khdour. Treatment of diabetic peripheral neuropathy: a review Pharmacotherapy // Journal of Pharmacy and Pharmacology. Pharmaceutical Society, 2020. No.72. Р. 863–872.
Sandra Sif Gylfadottira, Diana Hedevang, Sia Kromann Nicolaisenc, Henning Andersena. Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes // 2020 Volume 161 Number 3. Р 575-576.
